Evidence map›Paper›PMID 34908912›Full record

ArticleContrast media & molecular imaging2021

Drug-Target Interaction Prediction Based on Multisource Information Weighted Fusion.

Shuaiqi Liu, Jingjie An, Jie Zhao, Shuhuan Zhao, Hui Lv, ShuiHua Wang

Abstract read
In one paragraph

Article in Contrast media & molecular imaging, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Shuaiqi LiuCollege of Electronic and Information Engineering, Hebei University, Baoding 071000, China.ORCID 0000-0001-7520-8226
Jingjie AnCollege of Electronic and Information Engineering, Hebei University, Baoding 071000, China.
Jie ZhaoCollege of Electronic and Information Engineering, Hebei University, Baoding 071000, China.
Shuhuan ZhaoCollege of Electronic and Information Engineering, Hebei University, Baoding 071000, China.ORCID 0000-0001-5518-7368
Hui LvBeagledata Technology (Beijing) Co. Ltd., Beijing 100089, China.
ShuiHua WangSchool of Architecture Building and Civil Engineering, Loughborough University, Loughborough LE11 3TU, UK.ORCID 0000-0003-4713-2791

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recently, in most existing studies, it is assumed that there are no interaction relationships between drugs and targets with unknown interactions. However, unknown interactions mean the relationships between drugs and targets have just not been confirmed. In this paper, samples for which the relationship between drugs and targets has not been determined are considered unlabeled. A weighted fusion method of multisource information is proposed to screen drug-target interactions. Firstly, some drug-target pairs which may have interactions are selected. Secondly, the selected drug-target pairs are added to the positive samples, which are regarded as known to have interaction relationships, and the original interaction relationship matrix is revised. Finally, the revised datasets are used to predict the interaction derived from the bipartite local model with neighbor-based interaction profile inferring (BLM-NII). Experiments demonstrate that the proposed method has greatly improved specificity, sensitivity, precision, and accuracy compared with the BLM-NII method. In addition, compared with several state-of-the-art methods, the area under the receiver operating characteristic curve (AUC) and the area under the precision-recall curve (AUPR) of the proposed method are excellent.

Indexed as

AlgorithmsDrug DiscoveryDrug Delivery SystemsDrug InteractionsROC Curve

Identifiers

PMID34908912
PMCPMC8635946

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.